Skip to main content

MJFF Publications

541 - 550 of 7616 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • RESTRICTED
    Title: Valbenazine as treatment for Huntington's disease chorea
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
    Journal Name: Clinical Epidemiology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/clep.s405325
    Citation Count: 0
  • RESTRICTED
    Title: Sex and Gender Influence Urinary Symptoms and Management in Multiple System Atrophy
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.23016
    Citation Count: 1
  • RESTRICTED
    Title: PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00555
    Citation Count: 7
  • RESTRICTED
    Title: The contributions of mitochondrial and nuclear mitochondrial genetic variation to neuroticism
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-38480-y
    Citation Count: 2
  • RESTRICTED
    Title: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853
    Citation Count: 3
  • RESTRICTED
    Title: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad026
    Best OA location URL:
    Citation Count: 3
  • RESTRICTED
    Title: Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12111469
    Citation Count: 1
  • RESTRICTED
    Title: Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad169
    Citation Count: 5
  • RESTRICTED
    Title: Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-023-00486-5
    Citation Count: 2
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.